4//SEC Filing
Rill Donna R 4
Accession 0001140361-13-003196
CIK 0001069308other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:48 PM ET
Size
6.7 KB
Accession
0001140361-13-003196
Insider Transaction Report
Form 4
Rill Donna R
Senior V.P. of Operations
Transactions
- Award
Employee Stock Option (right to buy)
2012-09-12+10,469→ 10,469 totalExercise: $3.80From: 2012-09-12Exp: 2022-01-06→ Common Stock (10,469 underlying)
Footnotes (2)
- [F1]On January 6, 2012, the reporting person was granted an option to purchase an aggregate of 31,408 shares of common stock at the closing market price on such date. The option is performance based and begins to vest quarterly over a three-year period in two tranches commencing upon Opexa achieving certain key milestone events. The key milestone for vesting commencement of the first tranche of 10,469 shares is Opexa initiating a clinical trial for Tcelna in Secondary Progressive Multiple Sclerosis. The key milestone for vesting commencement of the second tranche of 20,939 shares is Opexa entering into a collaboration, partnership or other strategic arrangement involving rights in the United States for Tcelna. The performance criteria for the first key milestone has been met, resulting in commencement of three-year quarterly vesting for the first tranche of 10,469 shares reported herein.
- [F2]All share numbers and the exercise price have been adjusted to reflect the one-for-four reverse stock split implemented December 14, 2012.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001395070
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:48 PM ET
- Size
- 6.7 KB